Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
10.83%
operating margin TTM
16.56%
revenue TTM
662.57 Million
revenue per share TTM
3.45$
valuation ratios | |
|---|---|
| pe ratio | 32.96 |
| peg ratio | -1.00 |
| price to book ratio | 1.89 |
| price to sales ratio | 3.58 |
| enterprise value multiple | 21.29 |
| price fair value | 1.89 |
profitability ratios | |
|---|---|
| gross profit margin | 77.13% |
| operating profit margin | 16.56% |
| pretax profit margin | 14.98% |
| net profit margin | 10.83% |
| return on assets | 4.59% |
| return on equity | 5.82% |
| return on capital employed | 7.81% |
liquidity ratios | |
|---|---|
| current ratio | 5.21 |
| quick ratio | 3.50 |
| cash ratio | 1.73 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 643.42 |
| operating cycle | 746.33 |
| days of payables outstanding | 154.93 |
| cash conversion cycle | 591.40 |
| receivables turnover | 3.55 |
| payables turnover | 2.36 |
| inventory turnover | 0.57 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.08 |
| debt equity ratio | 0.11 |
| long term debt to capitalization | 0.09 |
| total debt to capitalization | 0.10 |
| interest coverage | 48.95 |
| cash flow to debt ratio | 1.29 |
cash flow ratios | |
|---|---|
| free cash flow per share | 3.78 |
| cash per share | 8.14 |
| operating cash flow per share | 4.32 |
| free cash flow operating cash flow ratio | 0.88 |
| cash flow coverage ratios | 1.29 |
| short term coverage ratios | 95.34 |
| capital expenditure coverage ratio | 8.04 |
Frequently Asked Questions
When was the last time BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) reported earnings?
BioMarin Pharmaceutical Inc. (BMRN) published its most recent earnings results on 28-10-2025.
What is BioMarin Pharmaceutical Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)'s trailing twelve months ROE is 5.82%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. BioMarin Pharmaceutical Inc. (BMRN) currently has a ROA of 4.59%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did BMRN's net profit margin stand at?
BMRN reported a profit margin of 10.83% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is BMRN's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 5.21 in the most recent quarter. The quick ratio stood at 3.50, with a Debt/Eq ratio of 0.11.